Visalytics
Visalytics
approved EB-2 (NIW)

Research Fellow

Biotechnologies · Iran · 2023-03-14

Processing Time
152 days
Decision Date
2023-03-14
Location
North Carolina
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance the understanding of cellular and molecular causes of chemotherapy toxicity on the cardiovascular system to develop protective and therapeutic interventions. Her work involves designing rodent models of psychosocial stress as a comorbid condition and developing exercise protocols to mitigate adverse chemotherapy effects. She intends to continue publishing original biotechnology research in peer-reviewed journals and presenting at conferences.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses chemotherapy-induced cardiotoxicity and syndromes like MFS, which impacts hundreds of thousands of Americans.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and history of NIH/NSF funding demonstrate she is well-positioned to succeed.

3 Waiver Benefit Met

On balance, the petitioner's specialized expertise in biomedical engineering makes her an invaluable asset, justifying the waiver of labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biomedical engineering and a record of 39 citations. She authored 3 peer-reviewed journal articles and completed 4 peer-reviewed article reviews. The case was further supported by 4 expert recommendation letters and evidence of research funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Cardiologist

Healthcare · India

WeGreened EB-2 (NIW) approved
Ohio 19 days 2025-04-23
The petitioner proposes to investigate a range of drugs, interventional procedures, and therapeutic strategies aimed at managing cardiovascular diseases in adults undergoing cancer treatment. This work focuses on mitigating the cardiotoxic effects of chemotherapy and optimizing cardiovascular treatment pathways to reduce long-term risks for oncology patients.
View Case

Physician

Healthcare · China

WeGreened EB-2 (NIW) approved
8 days 2023-08-08
The petitioner proposes to advance the development of new treatments for prevalent medical disorders, specifically cancer, heart failure, and heart attacks, by conducting research on disease mechanisms. Her work focuses on improving the diagnosis, treatment, and prevention of these leading causes of global mortality.
View Case

Postdoctoral Researcher

Biotechnology · Venezuela

WeGreened EB-2 (NIW) approved
Maryland 44 days 2023-02-22
The petitioner proposes to continue testing new drugs using spectral flow cytometry, extracellular vesicle isolation, and Western blotting to determine molecular mechanisms of various health conditions like inflammatory cardiovascular diseases. The work aims to develop novel treatments and create new ways to screen for patient receptiveness to immunotherapy, reducing the reliance on chemotherapy.
View Case

Physician

Healthcare · Brazil

WeGreened EB-2 (NIW) rfe approved
212 days 2025-12-24
The petitioner proposes to continue conducting clinical research leveraging extensive healthcare and literature databases to identify factors influencing cardiovascular outcomes in cancer survivors and patients with heart failure. This work aims to develop more effective prevention strategies and treatment decisions for patients facing elevated cardiovascular risks.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-03-14.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 152 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist